Merit Medical Systems is a medical instruments & supplies business based in the US. Merit Medical Systems shares (MMSI) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $93.76 – a decrease of 1.96% over the previous week. Merit Medical Systems employs 6,950 staff and has a trailing 12-month revenue of around $1.3 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $93.76 |
|---|---|
| 52-week range | $62.58 - $101.60 |
| 50-day moving average | $94.04 |
| 200-day moving average | $82.64 |
| Wall St. target price | $107.91 |
| PE ratio | 47.1095 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $2.01 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $93.76 from 2024-10-10
| 1 week (2024-10-04) | -1.96% |
|---|---|
| 1 month (2024-09-12) | -2.31% |
| 3 months (2024-07-12) | 8.59% |
| 6 months (2024-04-12) | 29.09% |
| 1 year (2023-10-12) | 49.01% |
|---|---|
| 2 years (2022-10-12) | 66.95% |
| 3 years (2021-10-12) | 30.13% |
| 5 years (2019-10-11) | 236.42% |
Valuing Merit Medical Systems stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Merit Medical Systems's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Merit Medical Systems's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 47x. In other words, Merit Medical Systems shares trade at around 47x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Merit Medical Systems's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.1957. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Merit Medical Systems's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Merit Medical Systems's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $246.3 million.
The EBITDA is a measure of a Merit Medical Systems's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1.3 billion |
|---|---|
| Operating margin TTM | 13.68% |
| Gross profit TTM | $519.1 million |
| Return on assets TTM | 4.48% |
| Return on equity TTM | 9.45% |
| Profit margin | 9.02% |
| Book value | $22.04 |
| Market Capitalization | $5.5 billion |
TTM: trailing 12 months
We're not expecting Merit Medical Systems to pay a dividend over the next 12 months.
Merit Medical Systems's shares were split on a 5:4 basis on 5 May 2011. So if you had owned 4 shares the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Merit Medical Systems shares – just the quantity. However, indirectly, the new 20% lower share price could have impacted the market appetite for Merit Medical Systems shares which in turn could have impacted Merit Medical Systems's share price.
Over the last 12 months, Merit Medical Systems's shares have ranged in value from as little as $62.58 up to $101.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Merit Medical Systems's is 0.871. This would suggest that Merit Medical Systems's shares are less volatile than average (for this exchange).
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers.
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out the best-performing ETFs so far in 2024.
Read our beginner’s guide to trading options in the US.